MORGELLONS SURVEY / EVIDENCE REVIEW
Bartonella and ticks
Four tick-field studies. Two Morgellons patient studies. A clearer account of detection, transmission and what remains uncertain.
Bartonella is not an established human tickborne infection. Recent field surveys weigh against a substantial transmission role for the principal U.S. Lyme-vector ticks. Laboratory experiments have nevertheless demonstrated transmission under particular conditions. Those findings address different questions; both belong in an accurate account.[1][7][8][9]
Bartonella findings in Morgellons patients
Two 2018 papers reported positive Bartonella henselae findings in selected Morgellons patient groups. These patient results belong alongside the tick evidence, with their tests and denominators kept distinct.
Morgellons patient studies / 2018
What the patient tests found
Reported test positivity · separate denominators · shared 0–100% scale
Middelveen and colleagues · 30-patient study[11]
Volunteers had healthcare-professional documented cutaneous filaments. Blood was tested from all 30; skin was tested from ten.
FISH means fluorescence in situ hybridization. The 30% result refers to the ten skin-tested patients, not all 30. PCR and FISH positives overlap and should not be added.
Fesler and colleagues · clinical cohort[12]
The analysis included 60 Morgellons-classified patients from a practice that screened 1,000 Lyme-seropositive patients.
What these studies add. They document positive Bartonella test findings in Morgellons patients. These selected samples do not establish a rate for everyone using the label, the cause of their skin findings, or acquisition through a tick bite. Patient testing and tick-transmission evidence answer different questions.
The practical question is whether a tick bite can be assumed to explain a person’s Bartonella infection. A positive Bartonella result, a history of tick bites, or concurrent Lyme disease does not by itself identify the route of acquisition. Establishing that route requires evidence linking the organism, vector and host.
What the four field studies found
These studies examined different tick species and feeding states in different places. They can be read together for context, while their results should remain tied to their individual sampling designs.
| Study | Ticks | Sampling context | Assay | Result |
|---|---|---|---|---|
| U.S. host-seeking · 2024 | 2,607 | I. scapularis: 1,641 from 23 eastern states (2013–2023); I. pacificus: 966 from Mendocino County, California (2004). | Quadruplex PCR + sequencing | No Bartonella DNA detected on any target.[1] Read Bai et al., 2024 — U.S. host-seeking ticks |
| U.S. blood-fed · 2024 | 853 | 792 I. scapularis, 45 I. pacificus, 16 I. angustus, collected from rodents in Minnesota (2016) and Washington (2019). | Quadruplex PCR + sequencing | One larva yielded a single-target sequence: presumptive Bartonella presence; species identification unconfirmed.[2] Read Bai et al., 2024 — U.S. blood-fed ticks |
| Finland · 2025 | 6,081 screened | Ticks removed from dogs and cats in 2015, overwhelmingly adults; abstract identifies 3,697 I. ricinus + 2,355 I. persulcatus = 6,052. | Multiplex qPCR | No Bartonella detected. The full-text screened count and abstract’s identified-species count are distinguished here.[3] Read Sormunen et al., 2025 — Finland, ticks from pets |
| Germany · 2025 | 692 | 339 D. reticulatus + 353 I. ricinus; mixed host-seeking and host-associated collection, 2021–2024. | Multiplex qPCR | No Bartonella detected. This was a nationwide pilot with a modest sample per state.[4] Read Köppen et al., 2025 — Germany |
On small screens, scroll the table horizontally. Each link names the actual study and country.
Explore the sample count
Where “over 10,000” comes from
Bar lengths show sample sizes on the same scale. Color identifies the testing approach, not the strength of an individual study. Select datasets to inspect the arithmetic.
2,607 + 853 + 6,081 + 692 = 10,233
Using the Finnish abstract’s 6,052 identified ticks gives 10,204. Selecting only the two U.S. quadruplex studies gives 3,460. This is a descriptive sum, not a pooled infection rate. The Finnish and German studies did not use the CDC quadruplex assay.
Why two Finnish counts? The methods and results say 6,081 samples were screened. The abstract lists 6,052 ticks identified to the two named species. We retain the authors’ labels rather than silently treating those as the same denominator. Both totals are visible in the interactive calculation.[3]
What quadruplex PCR adds
Bai and colleagues developed their assay in 2023 to amplify and sequence four Bartonella gene targets: gltA, groEL, rpoB and ssrA. Their species-confirmation objective required specific sequences from at least two targets. Testing included 24 reference species and non-Bartonella controls. A 2024 corrigendum replaced a duplicated supplementary figure; the authors reported no change to their conclusions.[5][6]
Broader detection and confirmation
Multiple targets help address Bartonella’s genetic diversity and provide more information for species identification than one target alone. The two U.S. field surveys applied this approach.[1][2][5]
Limits still apply
A molecular assay detects genetic material. It does not itself show that bacteria are alive, reach saliva, survive a molt, or infect another host. This research also does not establish clinical sensitivity for every human infection or validate a commercial patient test.
The newer assay makes the U.S. surveys particularly relevant to older, discordant tick-PCR findings. It does not automatically invalidate every earlier detection or transmission experiment. Laboratory transmission, field occurrence and human infection require different kinds of evidence.
Exposure without frequent tick detection
The blood-fed study also sampled rodents and fleas. Bartonella was commonly detected in those samples, yet was absent or presumptive in the ticks. This helps address whether the ticks simply had no opportunity to encounter the bacteria.[2]
Rodents, fleas and ticks in the same field study
Bartonella DNA detection, as reported in Bai et al. (2024). Different sample types and denominators are shown explicitly. This is not a comparison of human infection risks.[2]
Minnesota · 2016 field collection
Scale: 0–50% for every bar. The presumptive tick result is too small to form a prominent bar at this scale. In Washington, the results were 12/43 rodents (27.9%), 19/42 fleas (45.2%) and 0/61 ticks. Feeding stages varied; acquisition and onward transmission remain separate questions.
The laboratory evidence also belongs here
It would be too categorical to claim that ticks can never transmit any Bartonella species. Two frequently cited experiments show why.
2008 · artificial feeding
Cotté and colleagues infected I. ricinus through membrane feeding with B. henselae. They demonstrated survival across developmental stages and transfer of viable bacteria to blood in the experimental system. This supports laboratory capability under those conditions; it does not measure natural human transmission.[7]
2011 · transmission to mice
Reis and colleagues let ticks feed on a mouse infected with B. birtlesii. Infected nymphs subsequently transmitted the organism to previously uninfected mice. This directly demonstrates experimental vector competence for that tick–bacterium pairing, rather than establishing human transmission by the U.S. species surveyed in 2024.[8]
An organism’s ability to move through an experimental system and its importance as a vector in nature are different questions. The newer negative field surveys weigh against frequent natural carriage in the populations sampled; they do not erase demonstrated experimental transmission.
Read a finding at the level it supports
Open each finding to see what it establishes and what additional evidence would answer the next question. These are distinctions in inference, not a numerical scoring system.
DETECTIONBartonella DNA detected in a tick
A sequence establishes the presence of matching genetic material, subject to assay controls and confirmation. In a feeding tick, material can also originate from the blood meal.
To establish a transmissible infection, researchers must investigate viable organisms, persistence and onward transmission. A positive PCR result alone does not settle those questions.
EXPERIMENTAL CAPABILITYViable bacteria recovered or transmitted in a laboratory
Culture or a successful transmission experiment provides evidence beyond DNA detection. Tick species, bacterial species, exposure dose and experimental conditions define its scope.
The remaining questions concern whether the same process occurs in nature, how often it happens and whether people acquire infection through that route.
FIELD OCCURRENCENo detection in a field survey
Negative results provide evidence against high prevalence when the sampling and assay can detect what is being sought. Many negatives across a broad region can be informative.
The result still applies to the sampled populations and the method used. It cannot rule out very rare occurrence, another tick species or a different region.
HUMAN ACQUISITIONA person has Bartonella and a history of tick bites
The infection and exposure history may both be real. Their coexistence does not identify the vector. Alternative routes and timing still need consideration.
Attribution requires a credible chain of evidence linking an infected vector and the human infection, supported by vector biology and epidemiology. Co-diagnosis with Lyme does not supply that chain by itself.
These distinctions follow from the assay-development study, the different endpoints used in the field and laboratory papers, and CDC’s separation of animal experiments from evidence in people.[1][5][7][8][9]
What this means for patients
Bartonella infections are real, and their significance does not depend on proving a tick source. Different species have different established transmission routes. CDC identifies fleas and flea-associated cat exposure, human body lice and sand flies; cat scratch disease is the most common form of bartonellosis in the United States.[9]
CDC also acknowledges experimental tick-to-animal transmission and the uncertainty about whether it occurs in nature. For patients, a useful clinical history can include cat and flea exposure, body-louse exposure and relevant travel, as well as tick bites. A test result should be interpreted with symptoms, examination and the specific assay; it does not identify an acquisition route by itself.[9]
For people investigating Morgellons or persistent symptoms, the same standard should apply to every proposed explanation: document the finding, check what the test measures, and separate the diagnosis from a claim about its cause. This tick-surveillance review does not establish the cause of Morgellons or provide a treatment protocol.
Correction record: the numbers and the wording
Updated November 1, 2026. The AI review had endorsed the approximately 6,700 European ticks as a German-only count. On rechecking, it then overlooked the Finnish study and incorrectly questioned whether the author’s combined total exceeded 10,000. The author challenged that assessment, prompting recovery of the Finnish source. The figure combined Finland and Germany; the German paper itself reports 692 ticks. This was a failure of AI source checking and attribution. The underlying study data did not change, and the author’s original 10,000-plus combined total remains supported. The revised source list and country labels make that arithmetic explicit.[3][4]
Expanded November 2, 2026. Added the two 2018 Morgellons patient studies, with a separate graph of PCR, skin-FISH and serology results. Patient denominators remain separate from one another and from the 10,233-tick total.
| Earlier presentation | Corrected presentation and reason |
|---|---|
| Approximately 6,700 German ticks | Finland: 6,081 screened (6,052 identified to species in the abstract). Germany: 692. Europe totals 6,773 screened, or 6,744 using the identified-species Finnish count. Both explain the rounded European figure.[3][4] |
| 792 blood-fed ticks as the study total | 792 was the I. scapularis subset. Including 45 I. pacificus and 16 I. angustus gives 853. One larva had presumptive, single-target detection.[2] |
| An unclear 10,000-plus total | 2,607 + 853 + 6,081 + 692 = 10,233 screened. The abstract-based Finnish denominator yields 10,204. The count remains above 10,000; “well over” has been replaced with precise arithmetic. |
| Testing methods blurred together | The two U.S. studies used quadruplex PCR with sequencing. Finland and Germany used multiplex qPCR. The assay-development paper is context, not an extra field dataset. |
| “Bartonella Is Not a Tick Infection” | The title now describes what the studies show. The conclusion distinguishes unestablished human tick-bite transmission from demonstrated experimental transmission in particular tick–bacterium systems. |
The old in-article infographic has been replaced with source-linked displays. Its abbreviated claims should not be used as a substitute for this corrected evidence table. This update restores missing context and makes the counting choices inspectable.
Sources, with their roles labeled
References 1–4 supply the field-study count. References 5–6 concern the assay, 7–8 concern laboratory transmission, 9 is public-health guidance, and 10 documents a separate count that is excluded. References 11–12 supply the Morgellons patient findings and the separate clinical graph. A source appearing in the reference list does not mean its samples were added to the total.
- Bai et al., 2024 — U.S. host-seeking ticksBai Y, McClung KL, Osikowicz LM, Maes S, Eisen RJ. No evidence of Bartonella infections in host-seeking Ixodes scapularis and Ixodes pacificus ticks in the United States. Parasites & Vectors. 2024;17:345. Read the original publication.Field survey · quadruplex PCR plus amplicon sequencing · 2,607 ticks ↩ First citation
- Bai et al., 2024 — U.S. blood-fed ticksBai Y, Osikowicz LM, Clark J, et al. Bartonella infections are rare in blood-fed Ixodes scapularis and Ixodes pacificus ticks collected from rodents in the United States. Parasites & Vectors. 2024;17:442. Read the original publication.Field survey · quadruplex PCR plus amplicon sequencing · 853 ticks across three species ↩ First citation
- Sormunen et al., 2025 — Finland, ticks from petsSormunen JJ, Vesterinen EJ, Klemola T. Ticks and Tick-Borne Pathogens Encountered by Dogs and Cats: A North European Perspective. Transboundary and Emerging Diseases. 2025;2025:5574554. Read the original publication.Field survey · multiplex qPCR · 6,081 screened in the full text; 6,052 identified to species in the abstract ↩ First citation
- Köppen et al., 2025 — GermanyKöppen K, Zmarlak-Feher NM, Dörre A, Hagedorn P, Kohl C, Heuner K. Country-wide assessment of tick-borne pathogens collected in ticks between 2021 and 2024 in Germany, with a focus on Francisella: A one health pilot study. One Health. 2025;21:101190. Read the original publication.Field survey · commercial multiplex qPCR · 692 ticks ↩ First citation
- Bai et al., 2023 — assay developmentBai Y, Osikowicz LM, Hojgaard A, Eisen RJ. Development of a quadruplex PCR amplicon next generation sequencing assay for detection and differentiation of Bartonella spp. Frontiers in Microbiology. 2023;14:1243471. Read the original publication.Method development · four Bartonella gene targets · not an additional tick survey ↩ First citation
- Bai et al., 2024 — assay corrigendumBai Y, Osikowicz LM, Hojgaard A, Eisen RJ. Corrigendum: Development of a quadruplex PCR amplicon next generation sequencing assay for detection and differentiation of Bartonella spp. Frontiers in Microbiology. 2024;15:1360286. Read the original publication.Correction of Supplementary Figure S3 · authors report unchanged scientific conclusions ↩ First citation
- Cotté et al., 2008 — laboratory membrane feedingCotté V, Bonnet S, Le Rhun D, et al. Transmission of Bartonella henselae by Ixodes ricinus. Emerging Infectious Diseases. 2008;14(7):1074–1080. Read the original publication.Laboratory experiment · B. henselae · artificial feeding system ↩ First citation
- Reis et al., 2011 — experimental transmission to miceReis C, Cote M, Le Rhun D, et al. Vector Competence of the Tick Ixodes ricinus for Transmission of Bartonella birtlesii. PLOS Neglected Tropical Diseases. 2011;5(5):e1186. Read the original publication.Laboratory experiment · B. birtlesii · tick-to-mouse transmission ↩ First citation
- CDC, 2026 — current public-health guidanceCenters for Disease Control and Prevention. About Bartonella. Updated March 23, 2026; accessed November 1, 2026. Read CDC guidance.Public-health guidance · established routes and human tick-bite evidence ↩ First citation
- Chinnici, 2019 — Pennsylvania legislative testimonyChinnici N. Opening statement: public hearing on recommendations for ticks and tick-borne diseases in Pennsylvania. September 9, 2019. Pennsylvania General Assembly. Read legislative testimony (PDF).Legislative testimony · 6,700 Pennsylvania ticks · no Bartonella results reported; excluded from the count ↩ First citation
- Middelveen et al., 2018 — Morgellons patient testingMiddelveen MJ, Du Cruz I, Fesler MC, Stricker RB, Shah JS. Detection of tick-borne infection in Morgellons disease patients by serological and molecular techniques. Clinical, Cosmetic and Investigational Dermatology. 2018;11:561–569. Read the original publication.Clinical study · 30 volunteers · PCR and skin-subset FISH · Table 5 ↩ First citation
- Fesler et al., 2018 — selected clinical cohortFesler MC, Middelveen MJ, Stricker RB. Clinical evaluation of Morgellons disease in a cohort of North American patients. Dermatology Reports. 2018;10(1):7660. Read the original publication.Single-practice clinical cohort · 60 analyzed · Bartonella henselae seropositivity · Table 4 ↩ First citation